DrugPatentWatch Database Preview
Pegaspargase - Biologic Drug Details
Summary for pegaspargase
| Tradenames: | 1 |
| Patents: | 99 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for pegaspargase |
Recent Clinical Trials for pegaspargase
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Vanderbilt University | Phase 1 |
| Rong Tao | Phase 2 |
| Pfizer | Phase 1 |
Pharmacology for pegaspargase
| Ingredient-type | Asparaginase |
Patent Text Search: US Patents for pegaspargase
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sigma Tau | ONCASPAR | pegaspargase | VIAL | 103411 | 001 | 1994-02-01 | Start Trial | DuPont Pharmaceuticals Company (Wilmington, DE) | 2039-02-26 | RX | search | |
| Sigma Tau | ONCASPAR | pegaspargase | VIAL | 103411 | 001 | 1994-02-01 | Start Trial | Coraje, Inc. (San Francisco, CA) | 2039-02-26 | RX | search | |
| Sigma Tau | ONCASPAR | pegaspargase | VIAL | 103411 | 001 | 1994-02-01 | Start Trial | Bristol-Myers Squibb Pharma Company (Wilmington, DE) | 2018-04-21 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for pegaspargase
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Eurasian Patent Organization | 032434 | Start Trial |
| European Patent Office | 2244721 | Start Trial |
| Japan | 5464609 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
